These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32736779)

  • 1. Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer.
    Gerotziafas GT; Mahé I; Lefkou E; AboElnazar E; Abdel-Razeq H; Taher A; Antic D; Elalamy I; Syrigos K; Van Dreden P
    Thromb Res; 2020 Jul; 191 Suppl 1():S50-S57. PubMed ID: 32736779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study.
    Gerotziafas GT; Taher A; Abdel-Razeq H; AboElnazar E; Spyropoulos AC; El Shemmari S; Larsen AK; Elalamy I;
    Oncologist; 2017 Oct; 22(10):1222-1231. PubMed ID: 28550032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients.
    Rupa-Matysek J; Lembicz M; Rogowska EK; Gil L; Komarnicki M; Batura-Gabryel H
    Med Oncol; 2018 Apr; 35(5):63. PubMed ID: 29616356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External Validation of a Venous Thromboembolic Risk Score for Cancer Outpatients with Solid Tumors: The COMPASS-CAT Venous Thromboembolism Risk Assessment Model.
    Spyropoulos AC; Eldredge JB; Anand LN; Zhang M; Qiu M; Nourabadi S; Rosenberg DJ
    Oncologist; 2020 Jul; 25(7):e1083-e1090. PubMed ID: 32017293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal authoritative risk assessment score of Cancer-associated venous thromboembolism for hospitalized medical patients with lung Cancer.
    Xiong W; Zhao Y; Du H; Wang Y; Xu M; Guo X
    Thromb J; 2021 Dec; 19(1):95. PubMed ID: 34863189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM study.
    Abdel-Razeq H; Sharaf B; Al-Jaghbeer MJ; Abu-Fares H; Bater R; Shaer MA; Abu-Jaish H; Laban DA; Salamah O; Tamimi F; Ashouri K; Salameh T; Zughul R; Alhalaseh Y
    J Thromb Thrombolysis; 2023 Oct; 56(3):447-453. PubMed ID: 37430158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk prediction of venous thromboembolism in non-small cell lung cancer patients based on COMPASS-CAT risk assessment model].
    Wang YF; Ma F; Liu BL; Yang K; Li JL; Yu L
    Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):340-345. PubMed ID: 32375452
    [No Abstract]   [Full Text] [Related]  

  • 8. Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort.
    Verzeroli C; Giaccherini C; Russo L; Bolognini S; Gamba S; Tartari CJ; Schieppati F; Ticozzi C; Vignoli A; Masci G; Sarmiento R; Spinelli D; Malighetti P; Tondini C; Petrelli F; Giuliani F; D'Alessio A; Gasparini G; Minelli M; De Braud F; Santoro A; Labianca R; Marchetti M; Falanga A;
    J Thromb Haemost; 2023 Jul; 21(7):1869-1881. PubMed ID: 37054917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison among three predictive models for cancer-associated thromboembolism in a hispanic population.
    Ramos-Esquivel A; Marenco-Flores A; Hernández-Romero G; Céspedes-Calvo A; Mora-Hidalgo R
    J Thromb Thrombolysis; 2023 Oct; 56(3):433-438. PubMed ID: 37407771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Models for predicting venous thromboembolism in ambulatory patients with lung cancer: A systematic review and meta-analysis.
    Yan AR; Samarawickrema I; Naunton M; Peterson GM; Yip D; Newman P; Mortazavi R
    Thromb Res; 2024 Feb; 234():120-133. PubMed ID: 38215613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients.
    Di Nisio M; van Es N; Rotunno L; Anzoletti N; Falcone L; De Tursi M; Natoli C; Tinari N; Cavallo I; Valeriani E; Candeloro M; Guglielmi MD; Rutjes AWS; Porreca E
    J Thromb Thrombolysis; 2019 Jul; 48(1):125-133. PubMed ID: 30919253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study.
    Syrigos K; Grapsa D; Sangare R; Evmorfiadis I; Larsen AK; Van Dreden P; Boura P; Charpidou A; Kotteas E; Sergentanis TN; Elalamy I; Falanga A; Gerotziafas GT
    Oncologist; 2018 Nov; 23(11):1372-1381. PubMed ID: 30104289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control study.
    Hu Y; Li X; Zhou H; Lin P; Zhang J; Huang D; Qi M; Tang Y; Yi Q; Liang Z; Wang M
    Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):454-460. PubMed ID: 32910201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the risk of venous thromboembolism in patients with haematological cancers using three prediction models.
    El-Sayed HA; Othman M; Azzam H; Bucciol R; Ebrahim MA; El-Agdar MAMA; Tera Y; Sakr DH; Ghoneim HR; Selim TE
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17771-17780. PubMed ID: 37935936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Hepatocellular Carcinoma.
    Wang Y; Attar BM; Fuentes HE; Yu J; Zhang H; Tafur AJ
    Clin Appl Thromb Hemost; 2018 Apr; 24(3):471-476. PubMed ID: 28288526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.
    Pabinger I; van Es N; Heinze G; Posch F; Riedl J; Reitter EM; Di Nisio M; Cesarman-Maus G; Kraaijpoel N; Zielinski CC; Büller HR; Ay C
    Lancet Haematol; 2018 Jul; 5(7):e289-e298. PubMed ID: 29885940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients.
    Gomez-Rosas P; Giaccherini C; Russo L; Verzeroli C; Gamba S; Tartari CJ; Bolognini S; Ticozzi C; Schieppati F; Barcella L; Sarmiento R; Masci G; Tondini C; Petrelli F; Giuliani F; D'Alessio A; Minelli M; De Braud F; Santoro A; Labianca R; Gasparini G; Marchetti M; Falanga A; On Behalf Of The Hypercan Investigators
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating Venous Thromboembolism Risk in Metastatic Colorectal Cancer Inpatients: Validation of Existing Risk Scores and Development of New Risk Scores.
    Qin L; Liang Z; Xie J; Li X
    Clin Appl Thromb Hemost; 2023; 29():10760296231196859. PubMed ID: 37691565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma.
    Abdel-Razeq H; Ma'koseh M; Mansour A; Bater R; Amarin R; Abufara A; Halahleh K; Manassra M; Alrwashdeh M; Almomani M; Zmaily M
    Clin Appl Thromb Hemost; 2021; 27():10760296211045908. PubMed ID: 34590497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Biomarkers for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients.
    Schorling RM; Pfrepper C; Golombek T; Cella CA; Muñoz-Unceta N; Siegemund R; Engel C; Petros S; Lordick F; Knödler M
    Oncol Res Treat; 2020; 43(9):414-427. PubMed ID: 32580190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.